Swiss Life Asset Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$451K Sell
33,273
-2,607
-7% -$31.2K ﹤0.01% 1023
2026
Q1
$215K Buy
35,880
+2,533
+8% +$19.1K ﹤0.01% 1344
2025
Q4
$239K Buy
33,347
+21,822
+189% +$172K ﹤0.01% 1165
2025
Q3
$123K Buy
+11,525
New +$113K ﹤0.01% 1146
2023
Q1
Sell
-17,842
Closed -$500K 634
2022
Q4
$500K Buy
17,842
+205
+1% +$5.24K 0.01% 541
2022
Q3
$413K Buy
17,637
+613
+4% +$18.5K 0.01% 530
2022
Q2
$576K Buy
17,024
+7,168
+73% +$251K 0.01% 515
2022
Q1
$344K Sell
9,856
-2,370
-19% -$81K ﹤0.01% 542
2021
Q4
$372K Sell
12,226
-20
-0.2% -$651 ﹤0.01% 522
2021
Q3
$401K Sell
12,246
-11,245
-48% -$360K 0.01% 518
2021
Q2
$2.8M Buy
+23,491
New +$773K 0.03% 407

Other funds holding OGN

Swiss Life Asset Management's OGN Position: Q2 2026 in Review

Swiss Life Asset Management reduced its Organon & Co (OGN) stake by 7.3% in Q2 2026, selling an estimated $31.2K and leaving 33,273 shares worth $451K. The position accounts for ﹤0.01% of the portfolio, ranked #1023.

Swiss Life Asset Management first reported a position in OGN in Q2 2021 and has held it in 11 quarters since. The position peaked at $2.8M in Q2 2021. 437 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Swiss Life Asset Management held 33,273 shares of Organon & Co worth $451K as of Q2 2026.
  • Swiss Life Asset Management sold 2,607 Organon & Co shares in Q2 2026, an estimated $31.2K.
  • Organon & Co made up ﹤0.01% of Swiss Life Asset Management's portfolio in Q2 2026, its #1023 holding.
  • Swiss Life Asset Management first reported a position in Organon & Co in Q2 2021 and has held it in 11 quarters since.
  • Swiss Life Asset Management's Organon & Co position peaked at $2.8M in Q2 2021.
  • 437 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.